TY  - THES
AB  - Prostate-specific antigen (PSA)-based prostate cancer screening recommendations are going through drastic changes. The U.S. Preventive Task Services 2017 (current draft recommendation), American Cancer Society 2016, and National Comprehensive Cancer Network 2016 have updated their recommendations to include a shared decision-making (SDM) process for men when they are considering PSA testing. To ensure that the recommendations are followed in clinical practice, patient decision aids (PSA-PtDAs) are one strategy to support SDM. However, the effect of the PSA-PtDAs on men's intention to undergo PSA testing remains unclear. The purpose of this systematic review and meta-analysis was to answer the following key questions: (1) how do PSA-PtDAs compared with usual care affect men's prostate cancer screening behavior and (2) are computer-based interactive PSA-PtDAs more influential in changing men's screening intention than other types of decision aids?
AD  - Oregon Health and Science University
AU  - Ivlev, Ilya
DA  - 2017
DO  - 10.6083/m48s4p2x
DO  - DOI
ED  - Eden, Karen
ED  - Advisor
ID  - 7617
KW  - Intention
KW  - Prostatic Neoplasms
KW  - Early Detection of Cancer
KW  - Prostate-Specific Antigen
KW  - Choice Behavior
KW  - Decision Making
KW  - systematic review
KW  - meta-analysis
L1  - https://digitalcollections.ohsu.edu/record/7617/files/Ivlev.Ilya.2017.pdf
L2  - https://digitalcollections.ohsu.edu/record/7617/files/Ivlev.Ilya.2017.pdf
L4  - https://digitalcollections.ohsu.edu/record/7617/files/Ivlev.Ilya.2017.pdf
LK  - https://digitalcollections.ohsu.edu/record/7617/files/Ivlev.Ilya.2017.pdf
N2  - Prostate-specific antigen (PSA)-based prostate cancer screening recommendations are going through drastic changes. The U.S. Preventive Task Services 2017 (current draft recommendation), American Cancer Society 2016, and National Comprehensive Cancer Network 2016 have updated their recommendations to include a shared decision-making (SDM) process for men when they are considering PSA testing. To ensure that the recommendations are followed in clinical practice, patient decision aids (PSA-PtDAs) are one strategy to support SDM. However, the effect of the PSA-PtDAs on men's intention to undergo PSA testing remains unclear. The purpose of this systematic review and meta-analysis was to answer the following key questions: (1) how do PSA-PtDAs compared with usual care affect men's prostate cancer screening behavior and (2) are computer-based interactive PSA-PtDAs more influential in changing men's screening intention than other types of decision aids?
PB  - Oregon Health and Science University
PY  - 2017
T1  - Effect of patient decision aids on changes in men's prostate cancer screening behavior: a systematic review and meta-analysis
TI  - Effect of patient decision aids on changes in men's prostate cancer screening behavior: a systematic review and meta-analysis
UR  - https://digitalcollections.ohsu.edu/record/7617/files/Ivlev.Ilya.2017.pdf
Y1  - 2017
ER  -